REACH

December 6, 2022
European General Court Annuls Harmonized Classification and Labeling of Titanium Dioxide
September 29, 2022
EC Calls for Comment on Adding New Hazard Classes to CLP
September 28, 2022
EC Opens Call for Evidence on a Proposal for a Basic Regulation for ECHA
May 11, 2022
EC Opens Survey for Industry on Potential REACH Amendments Concerning the Generic Risk Management Approach and Authorization and Restriction
April 29, 2022
EC Publishes Restrictions Roadmap, Prioritizing Group Restrictions for the Most Harmful Chemical Substances
February 2, 2022
European Union Opens Consultation on Changes to EU REACH
January 3, 2022
Forecast for U.S. Federal and International Chemical Regulatory Policy 2022
September 1, 2021
EC Begins Targeted Consultation on Endocrine Disruptors, Will Hold Online Focus Groups in October
March 1, 2021
ECHA Begins Public Consultation on Derogation to the Exclusion Criteria for Creosote
December 16, 2020
Important Changes to Annex II to REACH Come into Force January 1, 2021
 1 2 3 >  View 10 | 25 | 50 | 100 per page
 
BERGESON & CAMPBELL, P.C.
2200 Pennsylvania Avenue, NW, Suite 100W
Washington, D.C. 20037
202-557-3800 • 202-557-3836 (fax) | lawbc.com
Contact • Twitter
 
Privacy Policy | Terms of Use | Cookie Policy | Attorney Advertising | Trademarks
©2023 Bergeson & Campbell, P.C.
All Rights Reserved.

We are very pleased to offer complimentary subscription to our informative newsletter(s), but we will need to collect some information to do so.

Please carefully read the provisions of the PRIVACY POLICY and the TERMS OF SERVICE ( click to read )

When you opt-in by clicking the button below, you agree to share your USER ID, EMAIL ADDRESS, COMPANY AFFILIATION, and JOB TITLE for the purpose of receiving our emailed newsletter(s).

If you do not accept these terms of use, do not subscribe to our newsletter(s).




I agree to the collection and use of my personal data as described above.


I do not agree to the collection and use of my personal data as described above and therefore agree not to access this subscription form.